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I. INTRODUCTION
Sperm donation is a well-accepted practice in the 21st century. It provides a comedic
plot line for more than a few popular movies where some mishap occurs in the sperm donation
process. In The Switch Jennifer Anniston unknowingly inseminates herself with her friend’s
sperm instead of her selected donor’s sperm; in Delivery Man Vince Vaughn discovers that an
error at a sperm bank led his sperm donations to conceive 533 children. In each of these movies
all parties involved—donor, parents, and children—get a happy ending and learn some lesson
about the meaning of family and love. However, incidents such as these do not just exist in feelgood comedies. Mishaps involving sperm donation are not uncommon. Recent trends with
direct to consumer testing, social media, and openness about the topic of sperm donation have
brought the incidents surrounding sperm donation into the public eye.
Sperm banks have given mothers the wrong sperm.1 Donors have lied about critical
pieces of medical and personal history.2 Sperm banks have failed to disclose information about
donors that any parent would want to know about the biological father of their child.3 In almost
any other industry these incidents would result in lawsuits. In the medical industry, such
mistakes would result in malpractice claims. In typical commerce, these “product” mix ups
would constitute a breach of contract or the basis of a products liability claim. But in the unique
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industry of sperm donation the alleged injury in these cases is ultimately the existence of a
child—a child genetically different than the child the parents had wanted. There are huge ethical
concerns with recognizing this child as a legal injury.
The reality is that the sperm donation industry operates largely without regulation to
prevent or deter these kinds of incidents. Existing Food and Drug Administration (FDA)
regulation offers little protection to consumers, and potential legal remedies are limited at best.
For decades the sperm banking industry, and the assisted reproductive technology (ART)
industry as a whole, was considered by many to be the “wild west” of the healthcare field. But
the prominence of sperm donation in modern family planning demands the enactment of a new
regulatory scheme that protects parents and children from trying to squeeze their unique “injury”
into the existing parameters of common law remedies. This comment will discuss the current
state of the sperm donation industry from a legal standpoint and the issues within it, and then
recommend a regulatory scheme that could help protect the people who rely on the industry to
start their families.
II. BACKGROUND
A. Increased Reliance on Sperm Donors
The increased use of and discussion surrounding sperm donation is largely linked to
increased infertility rates, both medical and “social” infertility. Couples are medically infertile if
they are unable to conceive after trying for one year.4 One in six couples experiences infertility.5
Male infertility—where the problem in conceiving is due to the male partner—is the sole cause
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World Health Organization, Infertility, https://www.who.int/reproductivehealth/topics/infertility/definitions/en/
(last visited Fall 2019).
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American Pregnancy Association, Male Infertility, https://americanpregnancy.org/infertility/male-infertility/ (last
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of infertility in about 20% of all infertility cases and is a contributing factor in about 30% of
cases.6 Male infertility usually occurs because of sperm abnormalities, inadequate numbers of
sperm, or ejaculation problems.7 These issues can be a result of a number of different disorders,
but the exact cause of these issues is unknown in almost half of all male infertility cases.8
Studies indicate that rates of male infertility are increasing,9 and with it the need for heterosexual
couples to rely on sperm donation to begin their families.10
“Social” infertility, sometimes called “circumstantial” infertility, is a term used to
describe couples or individuals who must rely on assisted reproductive technology (ART) to
reproduce because of their lifestyle as opposed to a medical condition.11 Changing social norms,
values, and lifestyles have caused more single women to procreate without a partner.12 Improved
social acceptance and recognition of legal rights has led more same-sex couples to have
biological children.13 Single women and same-sex female couples will, of course, have to rely
on sperm donation to conceive a child. Heterosexual couples may also choose to use a sperm
donor when genetic testing or family background indicates that the male has a high probability of
passing on an unwanted genetic disease or defect to a child.14
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It is difficult to find exact and accurate statistics reporting the number of children born
through sperm donation.15 The most reliable and commonly used statistic is from 2010, showing
that 30,000-60,000 of the 4 million babies born in the US that year were born through sperm
donation.16 However, social stigmas and the lack of nationalized reporting system mean that
many births from sperm donation likely go unreported indicating that the true number is likely
much higher.
B. The Sperm Donation Process
i. Donor Perspective
In order to apply to be a sperm donor, a man must be: (1) between 19 and 38 years old,
(2) currently attending or having graduated from college, (3) in good health, and (4) legally
allowed to work in the United States.17 First, a man interested in becoming a donor must fill out
an initial screening application online detailing his personal information, family background, and
education.18 Second, after passing the initial screening, the man must provide a semen sample.19
Third, if he passes the lab tests, the man must have a physical examination, meet with a genetic
counselor, complete a donor profile, and provide three photographs of the donor as a child.20 If
the potential donor completes these steps without issue, then the man becomes a qualified sperm

Wendy K.R. blog post “How Many Donor Offspring Are Really Out There Donor Sibling Registry
https://www.donorsiblingregistry.com/blog/how-many-donor-offspring-are-really-out-there/ (discussing the lack of
reporting and accurate numbers in the sperm donation industry and how outdated the “30,000-60,000 per year” is.
16
Ashley Fetters, The Overlooked Emotions of Sperm Donation, The Atlantic (Jul. 9, 2019),
https://www.theatlantic.com/family/archive/2018/07/sperm-donations-emotional-consequences/564587/.
17
Sperm Bank, Donor Requirements, https://www.spermbank.com/how-it-works/sperm-donor-requirements (last
visited Fall 2019).
18
Sperm Bank, Donor Screening Process, https://www.spermbank.com/how-it-works/donor-screening-process (Last
accessed Fall 2019).
19
Id. The semen must be screened for infectious disease. Some sperm banks screen semen for certain genetic issues
at this stage, too. This screening is a topic that will be discussed further in a later section
20
Id.
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donor.21 Most facilities request that each donor donate two to three times per week for at least a
year and require the donor to be tested every three months for infectious disease.22
Sperm banks cannot pay donors for sperm itself; the actual specimen must be legally
considered a donation. However, sperm banks pay donors up to $1500 monthly for their “time
and expenses” to get around the restriction on purchasing sperm.23 One sperm bank explains on
their website, “Sperm donors also receive periodic incentives such as movie tickets or gift
certificates for extra time and effort expended.” 24
At some point during this process the donor signs a contract legally giving up all parental
rights and responsibilities for any children resulting from their donation.25
ii. Parent Perspective
After parents decide to use a sperm donor, they must begin the process of choosing the
donor. Many fertility clinics maintain lists of preferred sperm banks.26 Parents use the sperm
bank website to view donor profiles.27 The design of these websites is quite similar to any online
retail website where shoppers can narrow down their search by specific criteria. Parents can
search based on a variety of characteristics: age, ethnicity, hair color, eye color, blood type,
height, educational degree, etc.28 Profiles include these basic traits and known family history of
heritable disease. Sperm banks usually offer “different tiers of information for more money.”29
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Parents can pay the sperm bank extra to get donor childhood photos, voice recordings, answers
to questionnaires, personality types, and sometimes even adult photos.30
After choosing a donor the parents order the sperm, usually to their fertility clinic.31 The
sperm bank delivers sperm in a special temperature-controlled container.32 At the clinic a doctor
either directly inseminates the mother with the sperm, or introduces the sperm to the egg in a
laboratory before transferring the fertilized egg into the uterus.33
iii. Costs
Each vial of “washed” sperm costs $800-$1000 and fertility clinics recommend ordering
three to six vials per cycle.34 Many women do not get pregnant from one cycle so parents must
pay this amount for as many cycles as it takes to get pregnant. This price also does not include
shipping, storage, and browsing fees.35 As mentioned above, there can be additional costs for
additional information about each sperm donor the parents are considering.36 These numbers do
not include any of the medical costs for consultations, inseminations, or any additional fertility
treatments the mother may need. Insurance companies may or may not cover some of these
costs depending on the state and particular insurance plan.37
C. Recent Cases and Controversies In The Sperm Donation Industry
i. Zelt v. Xytex Corp.

30

Id.
Emily Shiffer, How to Find A Sperm Donor And Get A Good One, Parents, (No Date?)
(https://www.parents.com/getting-pregnant/how-to-find-a-sperm-donor-and-choose-a-good-one/.
32
Id.
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Id.
34
“Washed” sperm is a specimen of sperm that has gone through several laboratory procedures to eliminate dead,
deformed, or immotile sperm to maximize the likelihood of successful fertilization.
35
https://www.vice.com/en_us/article/53nvex/why-is-sperm-so-damn-expensive
36
Id.
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Id.
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In an 11th Circuit case decided in February, 2019, the Zelts sued a sperm bank, Xytex.38
The Zelts had two children both conceived through insemination with the sperm of Donor #9623
which they purchased through Xytex.39 Xytex’s website promised they would screen potential
sperm donors through interviews and physical examinations.40 The Zelts decided on this
particular donor because Xytex stated that the donor was a Ph.D. candidate, had an IQ of 160, a
“nearly perfect” medical and mental health history, and no criminal background.41 Years after
their children were born the Zelts discovered that many of the representations about Donor
#9623—James Aggeles—were untrue: Aggles was diagnosed with schizophrenia and had been
repeatedly hospitalized for mental health reasons and drug use; he was considered disabled by
social security; had a felony conviction; was never enrolled in a Ph.D. program, and had only
finished college years after the Zelts purchased the sperm; and he had lied about his IQ.42
Aggles claimed that he had been encouraged to lie by a Xytex employee so that he would be
more successful in selling his sperm.43 Xytex never requested or verified his medical records
with health care providers, nor had they looked into his criminal and educational background
which would have been publicly available or easily accessible.44
The Federal District Court dismissed the complaint for failure to state claims for which
relief could be granted.45 The district court held that the claims were ultimately for wrongful
birth, which Georgia law does not recognize.46 The 11th Circuit affirmed this dismissal after

38

Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019).
Id. at 736.
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Id.
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Id.at 737.
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Zelt v. Xytex Corp., 766 F. App'x 735, 738 (11th Cir. 2019).
45
Id.
46
Id.
39

8

analyzing possible claims and agreeing that wrongful birth—unrecognized in Georgia—was the
only appropriate complaint for the matter.47 The Court stated that while they found the acts of
Xytex reprehensible, “We must affirm the dismissal of all of the Zelt’s claims that necessarily
entail pleading an injury equal to the difference in the value of a child’s life with Aggeles as the
sperm donor and the value of the child’s life with a different donor."48 The Court took moral
issue with labeling this controversy as “unjust enrichment.”49
ii. Cramblett v. Midwest Sperm Bank
Jennifer Cramblett sued Midwest Sperm Bank in 2014 after discovering that the facility
provided her with sperm from the wrong donor.50 Jennifer and her wife, both white themselves,
selected a white donor but some mix-up caused them to receive sperm from a donor other than
the one they selected.51 The sperm they received was from a black donor and the couple’s child
was “clearly biracial.”52 Cramblett sued under a wrongful birth claim.53 The complaint claimed
that sperm bank numbered the vials for identification with “pen and ink,” and that the records
were not computerized.54 The judge dismissed the case holding that it was not a wrongful birth
because the child has no health problems; courts maintain that there is no injury if the child is
healthy.55 As the comment will discuss in a later section, wrongful birth actions are dependent
on the child having some defect.56
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Id.
Id.
49
Zelt v. Xytex Corp., 766 F. App'x 735, 738 (11th Cir. 2019). (“Although the amount by which Xytex was
enriched is easy to calculate, calling this enrichment “unjust” necessarily implies that the Zelts’ children somehow
are worth less than they would have been worth had they been conceived using a different donor’s sperm.”)
50
Jaqueline Mroz, Their Children Were Conceieved With Donated Sperm. It Was the Wront Sperm., (June 3, 2019)
https://www.nytimes.com/2019/06/03/health/sperm-banks-fertility-artificial-insemination.html.
51
Id.
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See infra at 95
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iii. Doctors Using Own Sperm
There has been a great deal of press and discussion surrounding a recent string of
incidents where families have discovered—often through direct to consumer DNA testing—that
the sperm they received was not from their selected donor, but rather from their fertility doctor
himself.57 The most publicized recent story has been that surrounding Dr. Cline, an Indiana
fertility doctor who used his own sperm instead of sperm form anonymous young doctors in the
hospital as he had told the women.58 The women who were inseminated with Dr. Cline’s sperm
filed a complaint against him.59 Under Indiana law, however, such “infertility fraud” is not
legally cognizable.60 More than fifty people have discovered that they are his biological children
since the first accusation was made in 2014.61 Ongoing lawsuits in Idaho, Vermont, California,
Canada, and the Netherlands all have similar facts: former patients or their children bringing suit
against doctors accused of using their own sperm instead of donor sperm.62
D. Categorization of Incidents in the Sperm Donation Industry
Most of the cases and controversies surrounding sperm donation fall into one of four
categories: (1) “Unintentional False Profile”; (2) “Intentional False Profile”; (3) “Unintentional
Switch”; or (4) “Intentional Use of Wrong Sperm.”
Category (1), “Unintentional False Profile,” includes incidents where a sperm donor has
deliberately or mistakenly provided false information to the sperm bank, the sperm bank is
unaware of the falsity of the information, this information is entered into the donor profile,
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Mihir Zaveri, A Fertility Doctor Used His Sperm On Unwitting Women, N.Y. Times, (Aug. 30, 2018)
https://www.nytimes.com/2018/08/30/us/fertility-doctor-pregnant-women.html.
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Sarah Zhang, A Decades-Old Doctor’s Secret Leads to New Fertility-Fraud Law, The Atlantic, (May 7, 2019),
https://www.theatlantic.com/science/archive/2019/05/cline-fertility-fraud-law/588877/.
62
https://www.theatlantic.com/science/archive/2019/05/cline-fertility-fraud-law/588877/
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parents select the specific donor, and the mother is inseminated with the sperm of the selected
donor—the selected donor just has different traits than the profile described.63
Category (2), “Intentional False Profile,” includes incidents where a sperm donor
provides false information to the sperm bank and the sperm bank is aware of the falsity and
publishes the false information to a donor profile anyway, or where the sperm bank itself
encourages or creates the false information entered into the donor profile.64 As with the first
category, the parents then choose the donor profile representing this false information and are
inseminated with that donor’s sperm.
Category (3), “Unintentional Switch,” includes incidents where there is not an issue of
false donor information, but where parents select one donor, and the sperm bank mistakenly
provides the wrong donor’s sperm.65
Category (4), “Intentional Use of Wrong Sperm,” includes incidents where someone—
whether it be a sperm bank employee or a medical professional performing the insemination
procedure—intentionally provides sperm other than the selected donor sperm.66 This final
category presents a number of interesting and complex legal questions because the most
publicized stories have involved doctors using their own sperm instead of donor sperm. When a
doctor or other medical professional engages this kind of malicious deception malpractice seems
like the most appropriate course of action. This comment will discuss the limitations of
malpractice actions against the sperm banking industry as a whole in a later section. The legal
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FOODNOTE NEEDED (that case where everyone had the same genetic disease? Fragile X)
See, e.g., Zelt v. Xytex Corp., 766 F. App'x 735 (11th Cir. 2019). (Where an employee of the sperm bank new the
donor’s IQ was not 160, but encouraged him to list his IQ as 160 and then published this information on his donor
profile which the Zelts later selected).
65
See, e.g., Jaqueline Mroz, Their Children Were Conceieved With Donated Sperm. It Was the Wront Sperm., (June
3, 2019) https://www.nytimes.com/2019/06/03/health/sperm-banks-fertility-artificial-insemination.html. (Where the
Crambletts selected a white sperm donor and were inseminated by the sperm of a black donor).
66
See, e.g., Mihir Zaveri, A Fertility Doctor Used His Sperm On Unwitting Women, N.Y. Times, (Aug. 30, 2018)
https://www.nytimes.com/2018/08/30/us/fertility-doctor-pregnant-women.html.
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issues surrounding malpractice actions against solely medical professionals who intentionally use
the wrong sperm are outside the scope of this comment.
III. EXISTING REGULATION
A. Federal Regulation
i. Current FDA Regulation
Current federal regulation of sperm donation is minimal. The FDA classifies sperm
under the umbrella category of “human cell, tissue, and cellular and tissue-based product”
(HCT/Ps).67 In 2004, the FDA published three rules to regulate HCT/Ps: (1) Registration and
listing requirements, (2) donor eligibility requirements, and (3) good tissue practices.68 The
registration and listing rule states that “all establishments that recover, process, store, label,
package, or distribute HCT/Ps must register with the FDA and list their HCT/Ps.”69 The donor
eligibility requires all establishments to “screen and test cell and tissue donors for risk factors
for, and clinical evidence of, relevant communicable disease agents or disease.”70 The good
tissue practice rule sets forth practices that establishments should follow to prevent the spread of
communicable disease from infected donors and HCT/Ps within the facility.71 The practices
concern maintenance of collection practices, storage, labeling, packaging, distribution, etc.72 As
applied to sperm donation, these FDA regulations require sperm banks to register with the
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FDA, Donor Eligibility Final Rule and Guidance Q&A, https://www.fda.gov/vaccines-blood-biologics/tissuetissue-products/donor-eligibility-final-rule-and-guidance-questions-and-answers (last accessed Fall 2019).
68
Id.
69
21 C.F.R. § 1271.21
70
21 C.F.R. § 1271.45
71
21 C.F.R. § 1271.145
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Id.
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FDA,73 screen semen samples for communicable diseases,74 and implement practices that
prevent the spread of communicable disease through the semen.75
ii. Holes in Existing FDA Regulation
The eligibility rule is the only rule relevant to the testing and screening of sperm donors.
The rule currently only requires testing for communicable disease, like HIV. There are no
additional testing, examination, or interviewing requirements for sperm donors; the regulations
covering sperm donation are the same as those for blood and organ donation. The current FDA
regulations do not take into account the unique genetic importance of gametes—sperm and eggs.
B. State Regulations
New York State Department of Health has the strictest regulations in the country
regarding reproductive tissue banks. In addition to the FDA-required screenings for
communicable diseases, New York requires sperm banks to evaluate the genetic health of donors
for specific types of heritable diseases and disorders.76 The code states, “A complete medical
history, both individual and family, including first-degree and second-degree relatives, shall be
obtained from each reproductive tissue donor prior to any collection of tissues for clinical use. .
.” and continues to list a variety of malformations, genetic disorders, and behavioral factors that
may be inheritable by a child conceived from the sperm of the donor.77 The code states that,
except for those factors posing an increased risk for a communicable disease infection, the
aforementioned factors do not exclude a man from being a donor, but the reproductive tissue
bank’s medical director or attending physician shall counsel the recipient about potential risks of
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21 C.F.R. § 1271.21
21 C.F.R. § 1271.45
75
21 C.F.R. § 1271.145
76
N.Y. Comp. Codes R. & Regs. titl. 10, § 52-8.5
77
Id.
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using such a donor’s sperm.78 The New York code also implements a system for inspection of
reproductive tissue bank facilities.79
C. Industry Self-Regulation
i. American Association of Tissue Banks
The American Association of Tissue Banks (AATB) is the highest-level standard-setting
body for tissue banks in the US.80 Tissue banks receive AATB accreditation after submitting to
onsite inspections to ensure the bank is managed by professional and appropriate staff, and has
quality-assurance policies and procedures in place.81 There have been issues with some sperm
banks claiming to “meet or exceed” AATB standards without having been inspected or
accredited.82
ii. American Society for Reproductive Medicine
The American Society for Reproductive Medicine (ASRM) periodically issues
recommended guidelines for screening donors.83 The ASRM is an organization of physicians and
professionals in the industry who use their experiences and research to make recommendations
for best practices in the sperm donation industry. 84 These recommendations are only “industry
standards” and compliance is voluntary. 85
D. Foreign Regulations: United Kingdom

78

Id.
Id.
80
American Association of Tissue Banks, Accreditation, https://www.aatb.org/accreditation (last accessed Fall
2019).
81
Id.
82
Sperm Bank, Sperm Bank Registration, https://www.spermbank.com/about/sperm-bank-registration (last accessed
Fall 2019).
83
Id.
84
American Society of Reproductive Medicine, Vision of ASRM, https://www.reproductivefacts.org/aboutasrm/vision-of-asrm/ (last accessed Fall 2019).
85
Id.
79

14

Regulation of sperm donation varies globally based on social views, healthcare systems,
and medical technology. While the US government and regulators have taken a largely “hands
off” approach to sperm donation, the UK has taken the opposite approach; sperm donation in the
UK is heavily regulated.86 The Human Fertilisation and Embryology Authority (HFEA)
regulates all gamete (sperm and egg) donation in the UK.87 HFEA is the UK’s independent
regulator responsible for overseeing the use of gametes and embryos in fertility treatment and
research.88 All donors must register with HFEA prior to donating and HFEA enters all of the
donors into a national registry.89 Since 2005, all donors in the UK must agree to be identifiable
to any persons conceived from their donation once the person reaches the age of 18.90 The
national registry allows the HFEA to enforce a limit on the number of children a single sperm
donor may father to minimize the likelihood of “accidental incest.”91 A sperm donor in the UK
may not create more than ten families, but the donor himself may choose to further limit this
number.92
IV. APPLICATION OF PRIVATE LEGAL REMEDIES
A. Existing Legal Theories
i. Wrongful Conception

86

National Gamete Donation Trust, Donation and the Law, http://www.ngdt.co.uk/sperm-donor/donation-the-law/
(last accessed Fall 2019).
87
Id.
88
Id.
89
Human Fertilisation and Embryology Authority, Donating Your Sperm,
https://www.hfea.gov.uk/donation/donors/donating-your-sperm/ (last accessed Fall 2019).
90
Id.
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Id.
92
Id. Sperm donors are limited to a number of families rather than a number of children because many parents using
donor sperm may want to use the same donor to conceive multiple children. Ten families may be created by a single
sperm donor, but each family may have multiple children from that donor.
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In a wrongful conception action, the argument is that the plaintiff never wanted to
become pregnant in the first place; the legal harm is the pregnancy itself.93 In these actions,
pregnancy-related damages are allowed, but child-rearing damages are not allowed as childrearing is not a legally cognizable injury.94 Some states do not allow wrongful conception claims
for moral and policy reasons.95 Most states do allow wrongful conception actions, but claims
alleging the use of the wrong or substandard donor sperm do not fit into the parameters of the
action.96 In cases involving the use of a sperm donor the plaintiff clearly intended to become
pregnant, which undermines the basic theory of “wrongful conception” claims.97
ii. Wrongful Birth
In a wrongful birth action, plaintiff alleges that they wanted to become pregnant, but did
not want to give birth to a child with defects.98 A claim for wrongful birth arises from the
argument that the parents would have opted not to conceive or would have terminated the
pregnancy had the doctor properly advised them of the child’s risk for defects.99 Damages for
wrongful birth actions are commonly the difference between the cost of raising a healthy child
and the cost of raising the existing unhealthy child.100 As with wrongful conception, some states
refuse to recognize this cause of action for moral and policy reasons.101 Even in states that do
recognize wrongful birth, the use of the wrong sperm or less desirable sperm does not always

93

Fulton-DeKalb Hosp. Auth. v. Graves, 252 Ga. 441, 314 S.E.2d 653 (1984).
Id.
95
NOTE: Malpractice Claims Resulting from Negligent Preconception Genetic Testing: Do These Claims Present a
Strain of Wrongful Birth or Wrongful Conception, and Does the Categorization Even Matter?, 39 Suffolk U. L. Rev.
773
96
Id.
97
Id.
98
Id.
99
Id.
100
Id.
101
NOTE: Whose Sperm Is It Anyways In The Wild, Wild West Of The Fertility Industry?,34 Ga. St. U.L. Rev.
847.
94
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produce an unhealthy child.102 The resulting child is most often perfectly healthy, just having
different superficial attributes than the parents had desired.103 The issue becomes more complex
if the donor has heritable physical or mental health problems, but the child has not yet
manifested any problems and only has a certain probability of developing the problem. Courts
have grappled with how to properly award damages in these scenarios. Courts are also unwilling
to make any damage calculations based on the theory that a child born from one sperm donor is
worth less than one born from another donor.104
iii. Malpractice
Sperm banks primarily operate independently from fertility clinics or other medical
practices.105 After the parents select the sperm through the bank, the sperm bank delivers the
donor sperm to the medical practice for insemination.106 The doctor has no more of a way to
know whether or not the delivered vials contain the correct sperm than do the parents. Plaintiffs
can only bring malpractice suits against medical professionals, so if it was the sperm bank that
caused a mix-up of sperm the plaintiff cannot bring a malpractice claim because sperm banks
and their employees are not medical professionals.107
Malpractice suits could be appropriate in the cases of doctors using their own sperm to
inseminate patients since the doctor is the party committing the deception.108 While plaintiffs
could easily prove the duty and breach aspect of a malpractice claim in these cases against

102

Id.
Id.
104
See Zelt v. Xytex Corp., 766 F. App'x 735, 738 (11th Cir. 2019). See also Jaqueline Mroz, Their Children Were
Conceived With Donated Sperm. It Was the Wrong Sperm., (June 3, 2019)
https://www.nytimes.com/2019/06/03/health/sperm-banks-fertility-artificial-insemination.html.
105
NOTE: Whose Sperm Is It Anyways In The Wild, Wild West Of The Fertility Industry?,34 Ga. St. U.L. Rev.
847. (Many fertility clinics will have a “preferred list” of sperm banks they recommend, but normally the clinic and
sperm banks are entirely seperate entities)
106
Id.
107
Id.
108
FOOTNOTE NEEDED (need to find which Law Review article this came from)
103
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doctors, the same issues as discussed above will arise with characterizing the injury and
calculating damages. The feasibility of malpractice claims in this context, and the lack of legal
recourse against doctors specifically is largely outside the scope of this comment.
iv. Contract
Contract claims are of minimal use to parents in cases where they receive the incorrect or
“lower quality” sperm. Even if the parents prove that the sperm bank breached their contract, the
sperm bank can often avoid legal liability by relying on the doctrine of excuse, which applies
when the breaching party’s failure to perform “causes little material harm.”109 Where incorrect
or “lower quality” sperm is used, parents might be required to prove that the resulting genetic
qualities of the resulting child differ materially from the agreed upon terms of the contract.110
Parents will have to prove that these unwanted genetic qualities “are not merely incidental to the
contract they signed but that go to its very purpose.”111 If argued correctly, parents potentially
stand some chance of recovery if the resulting child has inherited a genetic disease or deformity
as a result of the sperm bank’s actions. Parents in these situations may be able to successfully
argue that they contracted for a healthy child free of genetic diseases, and that it was a material
breach for the sperm bank to furnish an unhealthy child. However, this legal theory would be
inapplicable to the types of incidents that are more likely to occur where the child is healthy but
possesses a different genetic makeup than the parents intended. In cases where the child is
healthy but having undesirable superficial genetic qualities the parents must argue that they did
not just contract for sperm to produce a healthy child, but for sperm to produce a healthy child
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with specific genetic qualities: sperm to produce a child with no inherited predisposition for
mental illness, sperm to produce a white child, sperm that is likely to produce a child with a
specific physical attributes. These types of arguments will likely be quashed by the materiality
doctrine.112
Looking to another aspect of contract law, courts will not typically award damages to
compensate for mental distress or emotional trauma resulting from a breach of contract.113
However, most jurisdictions recognize special circumstances in which damages for emotional
distress are recoverable.114 These circumstances arise where the defendant knew or should have
known of the special circumstances at the time the defendant entered into the contract. These
contracts are those that are “related to matters which concern directly the comfort, happiness, or
personal welfare of one of the parties, or the subject matter of which is such as directly to affect
or move the affections, self-esteem, or tender feelings of that party.” Courts have held that such
mental or emotional distress claims are appropriate for cases of contracts for mortuary and
crematorium services, or contracts for childcare.115 Mental or emotional distress contract claims
are arguably appropriate in cases involving wrongdoing on the part of a sperm bank. It is
undoubtedly upsetting for parents to discover that the father of their biological child is not the
person they selected. This selection of donor is a deeply personal choice. The mother in
particular may have emotional distress claims because of the violation she may feel after she was
inseminated with sperm other than the sperm she chose.116 It is possible that emotional and
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mental distress claims could be recoverable here. However, damage calculations for these types
of claims are still difficult, and as a matter of public policy courts may be opposed to allowing
parents to claim that their child has brought them emotional or mental distress.

B. Public Policy Concerns
Any private legal action against sperm banks in these incidents is going to necessitate a
finding of an injury and calculation of damages. The ultimate “injury” in these cases is a child
with a different genetic makeup than the parents had intended. As a matter of public policy,
courts are reluctant to conclude that the existence of a child is an “injury” or to make calculations
that one child is worth less than another.117 What is the dollar value of a healthy child? How
much less is an unhealthy child worth? How much less is a child with the “wrong” physical
appearance worth? How much less is the biological child of a man with a criminal record and
average IQ worth than the child of a Ph.D. candidate with an IQ of 160?118 It is easy to see why
courts fail to recognize these claims as legally cognizable. Courts do not want to stretch
common law or statutory rights of actions past their outer limits to encompass this class of
controversies that is impossible to ethically fit within the confines of existing doctrines. The
court is best to defer to the legislature on these legal questions that encompass such profound
public policy concerns.
C. Creation of New Statutory Rights of Action
i. Emerging Concept of “Fertility Fraud”

laws-go-after-misuse-of-sperm. (A woman who was inseminated by her doctor’s own sperm instead of her selected
donor sperm commented “I felt like I was raped 15 times and didn’t know it.”)
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As stories surface of doctors intentionally using their own sperm instead of the promised
donor sperm, or instead of the patient’s husband’s sperm, outrage at the limited legal recourse
has led some states to push for new legislation that would criminalize what has been labeled as
“fertility fraud.”119 This is a step in the right direction indicating that legislators understand the
severity of this act, but this criminalization would only apply in the category of “Intentional Use
Of Incorrect Sperm” and perhaps extending to severe misrepresentations in the category of
“Intentional False Donor Profile.” Many of the incidents that occur in the sperm donation
industry seem to result from negligence: sperm banks are negligent in delivering the correct
sperm to the correct parents, or in verifying the representations made by the donor. These
“fertility fraud” laws would offer no protection to parents who were victims of mere negligence
rather than malicious misrepresentations.
ii. Public Policy Concerns with Creating a Statutory Right
Legislators should be hesitant to create a statutory right of action that would give people
a right of action based on the “undesirable” genetic makeup of a child. It seems appropriate that
doctors and sperm banks that make intentional misrepresentations face some type of punitive
action. As the comment will later discuss, a stricter regulatory scheme should exist with a
punitive system for failure to comply with certain standards. However, giving parents a private
right of action against sperm banks raises some major and unavoidable policy concerns. First, as
discussed throughout the preceding section, the issue of damages will always raise ethical
concerns in this context. More importantly, perhaps, is the concern of how such litigation would
affect the child in question. It would be emotionally and psychologically devastating for a child
to discover that his or her parents sued because they were unhappy with his or her genetic
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characteristics. It is troubling to consider how the children at issue in cases like Zelt and
Cramblett will feel when they are old enough to search their name online and read the claims of
alleged damages their own parents made. Sperm banks should certainly be held to a higher
standard. Parents who have been victims of misrepresentation or negligence by sperm banks are
right to be upset. Nonetheless, the emotional and psychological well-being of the children in
these cases seems to be too high a cost to pay for a statutory right of action.
V. PROPOSED REGULATORY SCHEME
As demonstrated by the preceding sections, traditional legal remedies offer little recourse
to parents. Existing private remedies cannot comfortably encompass the type of injury alleged in
complaints brought by parents against sperm banks, and there are major public policy issues
involved with legislators creating statutory rights of action. Sperm banks have been getting
away with egregious acts of negligence and misrepresentation for decades, confident in their lack
of legal accountability and shielded by the reluctance of customers to publicize any incidents
because of the intensely private nature of sperm donation. The emphasis on donor privacy and
anonymity makes transparency impossible: the very nature of sperm donation allows the industry
to operate under the strictest secrecy.
Regulation is crucial where the nature of the industry prevents people from protecting
themselves. Regulation becomes even more crucial where it is the only line of defense.
Regulation is most important where, as here, there is minimal threat of civil liability, no criminal
action, and little to otherwise deter actors in the industry from taking advantage of people.
Current FDA regulation of the industry is minimal at best. As discussed above,
applicable FDA regulations focus on preventing the spread of communicable disease.120 There
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are no regulations unique to sperm banking; the FDA regulates sperm no differently than blood
and organs.121 The current regulations do not account for the unique genetic quality of sperm.122
These regulations do not account for the fact that sperm banks are selling sperm online like a
retail item on websites formatted similarly to online dating sites.123 The FDA should implement
a new regulatory scheme that is specific to gametes.
This section of the comment will propose a regulatory scheme intended to increase
protections for parents by increasing accountability in, and oversight of the sperm donation
industry.
A. Who Should Regulate The Sperm Donation Industry
The FDA has broad regulatory authority and has responsibilities “closely related to those
of several other government agencies.” 124 Among other things, the FDA regulates biologics
including blood and blood products, and tissue and tissue products. 125 The FDA considers
human reproductive tissue, sperm and eggs, tissue products and, thus, sperm is currently
regulated by the FDA. 126 It seems appropriate that the FDA continues to remain the regulating
authority of sperm. One might argue that the Federal Trade Commission (FTC) would be an
appropriate regulatory authority. The FTC regulates advertising and “protects consumers by
stopping unfair, deceptive, or fraudulent practices in the marketplace.127 There are clearly
pervasive issues of misrepresentation and deception in the sperm donation industry, and the
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sperm donation industry operates much like any other distributor of a consumer good.
Consumers of donor sperm could potentially stand to benefit if the FTC applied its standards and
regulations to the sperm donation industry. However, the creation of human life is far more
complex and important than almost any other consumer transaction. Being that the FDA is
already involved in the regulation of sperm, albeit only minimally, it seems most appropriate that
the FDA continue to be the regulatory authority overseeing the sperm banking industry.
An alternative option would be to create an independent regulatory agency, like the UK’s
HFEA, to oversee and regulate all embryo and gamete operations.128 This is a compelling option
given the unique characteristics of gametes, but this would be a huge leap to go from no
regulation unique to gametes, to an entirely new regulatory agency devoted specifically to the
industry. Making such a drastic jump in degree of regulation is just unrealistic at this time. As
scientific advancements increase the number of ART options, and as gene editing of embryos
looms on the horizon, the feasibility and necessity of creating such an independent regulatory
agency to specifically oversee gametes and embryos may increase.129
B. Recommended Regulation
i. Goals
The overarching goal of the recommended regulatory scheme is to increase protection for
consumers of donor sperm. New regulation would achieve this goal by increasing oversight of
and accountability in the sperm donation industry. Before articulating a regulatory
recommendation, it is important to consider the specific aims of the regulation. What is the
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regulation trying to prevent and require? What restrictions and requirements would protect
consumers from the harm they currently face in the industry?
It is helpful to consider each of the previously articulated categories of incidents resulting
from sperm banks’ conduct to determine what types of regulatory measures could prevent or
minimize each type of incident. First, “Unintentional False Profile” incidents are a result of an
omission by the sperm bank—a result of the sperm bank’s failure to adequately confirm the
background information the donor has provided about himself.130 Regulations that set a standard
for how sperm banks confirm donor information could help prevent this type of incident.
The second category of incidents, “Intentional False Information,” is the result of an
affirmative act by the sperm bank. The sperm bank is either publishing donor information it
knows to be false, or the sperm bank itself is encouraging the donor to provide false information,
or the sperm bank is just unilaterally publishing false information onto donor profiles.131 Since
this is an affirmative act by the sperm bank regulators cannot prevent it by implementing more
stringent confirmation checks of donor information; this type of conduct must be deterred by the
threat of some punitive action. Without much threat of legal remedy, there is currently little to
deter sperm banks from exaggerating or outright lying on donor profiles to increase profits by
listing more “desirable” donors.
The third category of incidents, “Unintentional Switch,” is a result of negligence by the
sperm banks. Some error in recording, labeling, storage, shipping, or the like results in a doctor
inseminating the mother with sperm from someone other than the donor selected.132
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Unfortunately, accidents like these are sometimes just the result of unavoidable human error that
would be unpreventable even with extensive regulation. However, some regulatory standards
should require that sperm banks be using modern and effective systems to minimize the
likelihood of error.
The fourth category, “Intentional Use of Wrong Sperm” can only be prevented by
creating a punitive system within the regulatory scheme to deter such behavior. As discussed
throughout the preceding sections, there is no existing legal remedies to hold doctors or sperm
banks accountable for these actions. The same punitive system that would effectively deter
intentional misrepresentations would be used to deter intentional use of wrong sperm.
In all categories of incidents, the secrecy that necessarily surrounds sperm donation
allows the sperm banks to continue to get away with this type of conduct. Sperm donors and
parents rely on and expect anonymity; the privacy of the donor and of the parents and their
resulting children are at the core of the entire process. Sperm banks can easily blame the secrecy
and lack of transparency on the need to protect these privacies, but it instead offers cover for
sperm banks to continue to get away with practices that would not likely be tolerated in any other
industry. Some implementation of facility inspection is essential to ensure that sperm banks are
operating in accordance with regulations since consumers have no way of overseeing this
themselves.
There are four overall objectives for increased FDA regulation for sperm banks. First, to
implement a system of confirming information provided by donors. Second, to enact punitive
actions to punish and deter intentional misrepresentations or intentional use of incorrect sperm.
Third, to require certain standards for labeling, organization, and distribution practices. Fourth,
to establish a system for the inspection of facilities and practices at those facilities.
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ii. Donor Profile Verification Requirement
Sperm banks must verify any donor information represented on the donor’s
profile. Regulations need not require that specific types of documents or other type of proof be
produced. However, verification must involve getting tangible proof from either official
documentation or confirmation by an appropriate third party. Regulations would ideally list
examples of appropriate verification practices: requiring official transcripts from claimed
educational institutions to prove degree, GPA, or honors; requiring W-2s to prove employment
in a specific field; requiring official reports from testing organizations to prove SAT scores or
IQ; requiring medical files with no gaps greater than eighteen months to verify medical
background. Sperm banks would not need to use these exact methods of verification to comply
with regulations. For example, perhaps the sperm bank could receive a list of all pertinent
medical history from the donor’s doctor,133 so the sperm bank need not comb through the donor’s
medical history itself. 134
Under this proposed regulatory scheme Xytex of the Xytex v. Zelt case would have
violated the requirement to verify donor profile information.135 Xytex failed to verify degrees,
current educational program, and testing scores of the donor.136 Xytex could have asked for a
number of different types of easily accessible proof—transcripts, bills, official score reports,
etc.—to verify the claims made by the donor.
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The regulations should also state that donors may rely on any documents or other form of
proof provided per the bank’s requirements so long as it is not unreasonable for the sperm bank
to do so. If a donor had somehow provided falsified documents, the sperm bank should only be
found to have violated FDA regulation for publishing this information to a donor profile if it was
unreasonable for the sperm bank to rely on the document or form of proof. For example, it
would be unreasonable for a sperm bank to rely on an “unofficial” transcript as proof of
enrollment in an educational program. However, a sperm bank would have fulfilled their duty to
reasonably verify the information if an official transcript with the seal of the institution or
delivered by the institution was found to be falsified; it would not be unreasonable for a sperm
bank to rely on such documentation.
In addition to requiring sperm banks to verify donor information, the proposed FDA
regulation would further require sperm banks to disclose its method of verification to parents.
The flexibility in the regulatory scheme would allow each sperm bank to decide what specific
forms of proof it wants to require donors to present. Some banks will likely do the bare
minimum to comply with this verification requirement while other banks go above and beyond
this requirement. Regardless, sperm banks must indicate what it means for information to have
been “verified” means at their facility. Does verifying a donor’s educational status mean
obtaining three separate types of documentation confirming the degree, or does it just mean
getting a single transcript? Either method would be in compliance with regulation, but parents
have a right to know what method was used in screening the biological father of their child.
Some parents may be comfortable relying on just the minimum regulatory requirement while
other parents may want—and be willing to pay more for—additional assurance. FDA
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regulations would require the sperm bank to make its donor verification procedures clearly
known on each donor profile.
The regulations would also require that the sperm bank disclose its method of verification
for each piece of information with sufficient detail so that parents are not confused or mislead.
For example, many sperm banks make claims that donors have undergone genetic testing. The
general public may not understand what “genetic testing” means in this context. Sperm banks
will almost certainly be testing for specific known, high-risk traits; banks will not be running a
full genome test on every donor. This means that sperm banks can confirm whether or not the
donor has a high likelihood of passing on the certain heritable diseases that it specifically tests
donors for. However, the donor could still have a high likelihood of passing on a heritable gene
for some trait that was not being tested for. Full genome testing is not necessary or practicable.
It is necessary for parents to understand that when a sperm bank indicates that a donor’s genetic
testing did not indicate any heritable diseases, or only had a low risk of some disease, that it does
not mean that the donor has been tested for every possible heritable disease.137
If a sperm bank is unable to verify certain claims made by the donor, this donor need not
automatically be excluded from becoming a donor. The sperm bank may still allow the man to
donate sperm, but the donor profile must not reflect any information that is not verified.
However, family medical history is a piece of information that most parents want to know but is
impossible to verify. Verifying this information would require privacy waivers from not just the
donor, but his parents, siblings, and grandparents; obtaining medical history verification from all
of these people is just not feasible.138 Therefore, sperm banks may disclose the donor’s reported
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family medical history on the donor profile—otherwise this information could never be included
on donor profiles. However, sperm banks must make it clear on the profile that the family
medical history is only reported by the donor and not able to be verified.
ii. Specimen Storage and Maintenance Requirement
New FDA regulation should require that all sperm banks utilize a computerized system to
organize, maintain, and distribute specimen. All specimen containers should be labeled with a
barcode—or an equivalent—and an alphanumeric code. Anytime a specimen is collected,
stored, moved, or distributed the barcode should be scanned for verification by a computer
program, and the alpha-numeric number should be checked by the human employee. This would
also create a computerized record of any date and time the specimen was moved. Each time
parents select a donor the donor profile should be linked to the alphanumeric code and barcode
which should be fixated automatically on the parents’ order or profile. This computer-dependent
system would help to prevent mix-ups like the one in Cramblett v. Midwest Sperm Bank where
the plaintiff claimed that sperm bank labeled specimen with pen and paper. With the advanced
state of computer technology there is no excuse for sperm banks to not use a computer program
to ensure accurate specimen handling.
iii. Punitive Action for Intentional Misrepresentations
FDA regulation should outline a punitive cause of action for sperm banks and employees
who knowingly or intentionally advertise false information about donors on the donor profiles.139
Regulations should classify such acts as “misbranding.”140 Fines and/or criminal action should
be determined based on the nature of the misrepresentation such that misrepresentations about
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something more superficial, like educational degree, are punished less severely than
misrepresentations about medical or mental health background.
These punitive actions should also apply against any medical professionals—doctors,
nurses, etc.—that are responsible for inseminating women with donor sperm. If a doctor were to
knowingly or intentionally inseminate a woman with the incorrect sperm, the doctor would also
be subject to any fines or criminal action. This addition to the regulations would provide parents
with some opportunity for punitive action against the doctors who used their own sperm to
inseminate unknowing women. Perhaps future legislation will allow parents to bring more
severe “fertility fraud” criminal action or malpractice actions against doctors who take these
deliberate deceptive actions. For now, including this venue for punitive action against medical
professionals will give parents at least some method of recourse.
iv. Enforcement Action
Failure to comply with FDA standards should result in enforcement action.141 The level
of the enforcement action by the FDA should be aligned with the nature and seriousness of the
violation.142 A first instance of failure to comply with standards where there was no resulting
harm (harm being a parent conceiving a child with misrepresented or incorrect sperm) would
result in a warning letter.143 Instances where harm did occur as a result of negligence—
inadequate steps to confirm background, or inadequate specimen management resulting in a
switch—but not an intentional misrepresentation would result in a fine.144 Incidents where harm
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occurred as a result of misrepresentation would result in a higher fine.145 The FDA could file
injunctions against sperm banks to cease noncomplying actions.146 Seizures and destruction of
specimens could occur if the FDA believed specimens to be mislabeled or misbranded.147 Sperm
banks could lose FDA licensing all together after repeat violations.148

v. Inspection
Currently, only New York State requires inspections of sperm donation facilities.
Ongoing inspection of facilities and practices is the best way to ensure compliance with
standards. Inspection is especially important in an industry such as the sperm donation industry
where the emphasis on anonymity and privacy allows the industry to operate with effectively no
transparency.
Under the proposed regulatory scheme sperm banks would be subject to biennial
inspections as well as unannounced inspections. During inspections, an FDA inspector would be
ensuring compliance with both donor profile verification requirements and specimen
maintenance requirements. To inspect specimen maintenance programs the inspector would
observe employee practices in collection, storage, and distribution. The inspector would ensure
that the sperm bank was using an appropriate computer program, employees were being trained
in proper specimen-handling procedures, and that employees were actually adhering to these
procedures.
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Inspections for compliance with donor profile verification requirements would be a bit
more tedious. Overall, the inspector would be looking to confirm that the information on donor
profiles was actually verified by the sperm bank and that the verification process was accurately
represented to the parents viewing donor profiles. This would require the inspector to observe
three different aspects of the sperm banks operations. First, the inspector would observe donor
interview procedures to see that employees are asking donors the right questions and gathering
the correct preliminary information. Second, the inspector would review randomly selected
confidential donor files and compare them to the donor profiles on the sperm bank’s website.
The inspector would be looking to see that every piece of information on the donor profile was
corroborated by some compliant verification document. Third, the inspector would review the
website and profiles to ensure that the method of verification the sperm bank has promised
parents is the method the sperm bank actually used; if the sperm bank says educational
background was verified by a transcript and a diploma photocopy then the inspector needs to
find both of those documents in the sperm bank’s file on the donor. If a sperm bank is found to
be in violation of any of the regulation requirements, then an appropriate enforcement or punitive
action would be taken.
C. Potential Limitations of Proposed Regulation
i. Over-regulation
It is important to strike a balance between too little and too much regulation over an
industry. Too little regulation and consumer safety and protection are at risk, but too much
regulation also has serious economic costs, the brunt of which falls on the lowest income
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consumers.149 Assisted reproductive technologies in their loosely regulated state are already
quite expensive, and many commentators note that assisted reproductive technology is a luxury
only available to the wealthy.150 Lower income Americans facing medical or social infertility
already struggle to access ART. Enforcing regulatory requirements in the sperm banking
industry will unavoidably raise expenses for sperm banks which they will pass off to consumers
in increased prices. While the wealthy will be unaffected by the increase, this increased expense
will make donor sperm even more burdensome or entirely unaffordable to lower income parents.

ii. Under Regulation
When compared to the UK’s HFEA, this proposed regulation seems under inclusive.151
As discussed above, the UK has an independent regulatory agency, a national sperm donor
registry, and a limit on the number of families that a donor may create.152 This comment has
already discussed the infeasibility of jumping from no unique regulation for the sperm banking
industry to establishing an entire independent regulatory agency. A limit on the number of
families that a donor may create is important.153 There are concerns about accidental
consanguinity from a population-genetics perspective.154 The American Society for
Reproductive Medicine recommends a limit of 25 births per a population of 800,000 but, of
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course, there is no assurance that this recommendation will be followed.155 Tracking the number
of children born from a donor requires parents to report if insemination is successful, but there is
no assurance that parents report births resulting from purchased sperm.156 The biggest obstacle
to complying with this recommended limit, however, is the reality that each sperm bank operates
entirety independently.157 There is no national donor registry, so a donor’s sperm may result in
however may births at one sperm bank, but then the donor can go to another sperm bank, say he
has never donated before, and there would be no way for the sperm banks to know of the other
donations and conceived children.158
Implementing a national sperm donor registry system has its pros, including allowing an
enforced limit on births per donor.159 A national registry would also increase regulatory
oversight and would arguably be a good addition to the proposed regulations above.160
However, national registries tend to decrease the number of men willing to donate sperm.161
Donating to a private, independent clinic seems to make men feel more comfortable with the
anonymity of the whole process.162 As with creating an independent regulatory agency, creating
a national donor registry would also be a fairly big leap from virtually no regulation of the sperm
industry. Creating a national registry should be a long-term goal for improving regulation of the
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sperm donation industry but implementing a basic system of standards and enforcement is a
more realistic primary goal for the time being.
VI. CONCLUSION
An increasing number of same-sex couples, single women, and infertile couples are
relying on sperm donation to grow their families. The current FDA regulation does nothing to
deter negligence and misrepresentation, and the harm parents suffer does not align with existing
common law legal remedies. These deficiencies undermine the parents’ control and autonomy in
a field where parents have no choice but to place total trust in sperm banks and their employees.
Since creating legal remedies that classify the birth of a child as an injury raises substantial
ethical and policy concerns, regulation is the best way to protect parents. A regulatory scheme
that increases oversight and accountability in the sperm banking industry will be a major step
towards taming the “wild west” of assisted reproductive technologies, and making the sperm
donation process more reliable for the parents who must rely on it to grow their families.
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